Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 841 record(s)

Req # A-2020-001398

Adverse Drug Reactions (ADRs). Report numbers: E2B_02923744, E2B_02923770, E2B_02923787, E2B_02923791, E2B_02923797, E2B_02923798, E2B_02924527, E2B_02924704, E2B_02924958, E2B_02925846, E2B_02926149, E2B_02926635, E2B_02926636, E2B_02927181, E2B_02927400, E2B_02927561, E2B_02928196, E2B_02928210, E2B_02928318, E2B_02928406.

Organization: Health Canada

389 page(s)
November 2023

Req # A-2021-000111

Adverse Drug Reactions (ADRs) for Cipralex. Report numbers: 913781, E2B_03222881, E2B_03209564, 914535, 913955, E2B_03201921, E2B_03242954, E2B_03260823 , E2B_03230378, 916963, 919987, E2B_03321958, 920020.

Organization: Health Canada

138 page(s)
November 2023

Req # A-2021-000439

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100121-662.

Organization: Health Canada

19 page(s)
November 2023

Req # A-2021-001029

Adverse Drug Reactions (ADRs). Report numbers: E2B_01899783, E2B_01918621, E2B_01958799, E2B_01983423, E2B_02123327, E2B_02125660, E2B_02183567, E2B_02201561, E2B_02260351, E2B_02230110, E2B_02229967.

Organization: Health Canada

261 page(s)
November 2023

Req # A-2021-001151

Adverse Drug Reactions (ADRs) for WHITE PETROLATUM. Report numbers: E2B_03905714, E2B_03905715.

Organization: Health Canada

14 page(s)
November 2023

Req # A-2021-001286

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-115999-83.

Organization: Health Canada

6 page(s)
November 2023

Req # A-2021-001349

Adverse Drug Reactions (ADRs) for METFORMIN HYDROCHLORIDE. Report numbers: 000931128, 000932921, 000932746, E2B_03792422, E2B_03813441, E2B_03547654, E2B_03787146, E2B_03771935, E2B_03774050, E2B_03892593.

Organization: Health Canada

132 page(s)
November 2023

Req # A-2021-001653

Adverse Drug Reaction (ADR) for LANSOPRAZOLE. Report number: E2B_04448096.

Organization: Health Canada

19 page(s)
November 2023

Req # A-2022-000165

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-103394-927.

Organization: Health Canada

65 page(s)
November 2023

Req # A-2022-000200

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-101391-582, Evaluation of the National COVID-19 Exposure Notification App.

Organization: Health Canada

50 page(s)
November 2023
Date modified: